38.86 USD
▼-0.69-1.74%
盘后 34.98 0.00%
2026-09-15
市值
$1.79B
市盈率
—
EPS
-0.54
股息率
—
52 周区间
14.00 – 51.10
成交量
269.39K
Beta
—
目标价
54.22
52W 低 14.0052W 高 51.10
价格走势
公司简介
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM f...